| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 11/24/2011 | CA2800065A1 Reagents and methods for treating cancer |
| 11/24/2011 | CA2800015A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| 11/24/2011 | CA2799989A1 Polycyclic quinazolines, preparation thereof, and use thereof |
| 11/24/2011 | CA2799944A1 Methods and compositions related to modulating autophagy |
| 11/24/2011 | CA2799773A1 Novel self-reactive arms and prodrugs comprising same |
| 11/24/2011 | CA2799764A1 Mtor selective kinase inhibitors |
| 11/24/2011 | CA2799579A1 Chemical compounds, compositions and methods for kinase modulation |
| 11/24/2011 | CA2799480A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases |
| 11/24/2011 | CA2799202A1 Compositions and methods for treatment of autoimmune and other diseases |
| 11/24/2011 | CA2798970A1 Pyrrolopyrazine derivatives as syk and jak inhibitors |
| 11/24/2011 | CA2798778A1 Anti-human trop-2 antibody having anti-tumor activity in vivo |
| 11/24/2011 | CA2791951A1 Biological materials related to her3 |
| 11/23/2011 | EP2388330A1 Liver engrafting cells, assays, and uses thereof |
| 11/23/2011 | EP2388320A1 Anti-hs6st2 antibody and use thereof |
| 11/23/2011 | EP2388315A2 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 11/23/2011 | EP2388275A2 An aglycosylated IgG1 antibody to CD3 |
| 11/23/2011 | EP2388263A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators |
| 11/23/2011 | EP2388259A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 11/23/2011 | EP2388255A1 Polysubstituted benzofurans and medicinal applications thereof |
| 11/23/2011 | EP2388014A1 Therapeutic application of tumoral immunoglobulin variable region peptides in patients with B-cell malignancies |
| 11/23/2011 | EP2388005A1 Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy |
| 11/23/2011 | EP2387609A2 Non-embryonic stem cells and uses thereof |
| 11/23/2011 | EP2387572A2 Protein kinase c inhibitors and uses thereof |
| 11/23/2011 | EP2387563A1 Malate salt of n- (4- { [ 6, 7-bis (methyloxy) quin0lin-4-yl]oxy}phenyl-n' - (4 -fluorophenyl) cyclopropane-1-dicarboxamide, and crystalline forms therof for the treatment of cancer |
| 11/23/2011 | EP2387560A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 11/23/2011 | EP2387559A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 11/23/2011 | EP2387421A1 Compounds comprising n-formyl-methionine residues and tumor-targeting peptides |
| 11/23/2011 | EP2387405A2 Pirenzepine as an agent in cancer treatment |
| 11/23/2011 | EP2387401A1 Method for treating colorectal cancer |
| 11/23/2011 | EP2387316A1 Fused amino pyridines for the treatment of brain tumors |
| 11/23/2011 | EP2260033B1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 11/23/2011 | EP2107906B1 Novel therapeutic use for treating leukaemia |
| 11/23/2011 | EP2035391B1 Indazole derivatives for treating hsp90-induced diseases |
| 11/23/2011 | EP2020996B1 Method and compositions for treating hematological malignancies |
| 11/23/2011 | EP2007732B1 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases |
| 11/23/2011 | EP1951674B1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 11/23/2011 | EP1866319B1 Phosphono-pent-2-en-1-yl nucleosides and analogs |
| 11/23/2011 | EP1864659B1 Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 11/23/2011 | EP1765328B1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody |
| 11/23/2011 | EP1735277B1 2-alkylidene-18,19-dinor-vitamin d compounds |
| 11/23/2011 | EP1727558B1 Use of dmbt1 for capturing sulphate and phosphate group exposing agents |
| 11/23/2011 | EP1509541B1 Novel recombinant anticoagulant proteins |
| 11/23/2011 | EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors |
| 11/23/2011 | EP1467976B1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 11/23/2011 | EP1391451B1 2-iminopyrrolidine derivates |
| 11/23/2011 | EP1349576B1 Combined use of enzyme inhibitors for the treatment and prevention of allergic reactions of type i according to the gell and coombs classification, and for the treatment and prevention of dermatological diseases associated with follicular and epidermal hyperkeratosis and reinforced keratinocyte proliferation |
| 11/23/2011 | EP1137439B2 Stabilization of rapamycins or derivatives of rapamycins |
| 11/23/2011 | CN202048757U Freeze dryer used for freeze-drying Cordyceps sinensis |
| 11/23/2011 | CN1671351B NSAID-containing topical formulations that demonstrate chemopreventive activity |
| 11/23/2011 | CN102257138A Tumor antigen peptide and use thereof |
| 11/23/2011 | CN102257008A Antibodies against human angiopoietin 2 |
| 11/23/2011 | CN102256989A Anionic conjugates of glycosylated bacterial metabolite |
| 11/23/2011 | CN102256980A 3-(3-pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyrimidine derivatives |
| 11/23/2011 | CN102256972A Thiazolyl-benzimidazoles |
| 11/23/2011 | CN102256943A Hemifumarate salt of 1- [4- [1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl] -2 -ethyl-benzyl] -a zetidine-3-carboxylic acid |
| 11/23/2011 | CN102256623A Neuroinvasion inhibitor |
| 11/23/2011 | CN102256616A Combination therapy with peptide epoxyketones |
| 11/23/2011 | CN102256603A Inhibitors of mitosis for increasing apoptosis in therapy |
| 11/23/2011 | CN102251013A Antibody and antigen for recognizing tumor initiator cell and application thereof |
| 11/23/2011 | CN102250918A Recombinant human interferon-like proteins |
| 11/23/2011 | CN102250904A Medicine for preventing and/or treating melanoma |
| 11/23/2011 | CN102250852A Clone and expression of bovine recombinant alpha-1,3-galactoside transferase (GT) |
| 11/23/2011 | CN102250735A Propolis wine combined with golden camellia and preparation method thereof |
| 11/23/2011 | CN102250734A Linearstripe rabdosia herb combined propolis wine and preparation method thereof |
| 11/23/2011 | CN102250733A Health-care wine matched with gynostemma pentaphylla and preparation method thereof |
| 11/23/2011 | CN102250342A PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound |
| 11/23/2011 | CN102250277A Macromolecular polymer capable of carrying medicine and used for embolism |
| 11/23/2011 | CN102250260A Enzyme engineering manufacturing method of functional glycan |
| 11/23/2011 | CN102250254A Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) fusion protein, its preparation and applications |
| 11/23/2011 | CN102250252A Gastrin-releasing peptide (GRP) guided fusion protein |
| 11/23/2011 | CN102250250A Human-mouse chimeric anti-human CD19 antibody Hm2E8b and use thereof |
| 11/23/2011 | CN102250249A Anti-VEGF/PDGFR (Vascular Endothelial Growth Factor/Platelet-Derived Growth Factor Receptor) beta double-specificity antibody and application thereof |
| 11/23/2011 | CN102250248A Anti-VEGF/ANG2 bispecific antibody, and application thereof |
| 11/23/2011 | CN102250247A Bispecific antibody to VEGF/ANG2 and application thereof |
| 11/23/2011 | CN102250246A Bispecific antibody to VEGF/PDGFR beta and application thereof |
| 11/23/2011 | CN102250245A Bispecific antibody capable of resisting B cell lymphoma and application thereof |
| 11/23/2011 | CN102250244A Human prolactin receptor antibody and application thereof |
| 11/23/2011 | CN102250223A Molecular improved apoptin (30-121) as well as preparation method and application thereof |
| 11/23/2011 | CN102250211A HLA-A*3303-Restricted WT1 Peptide and pharmaceutical composition comprising the same |
| 11/23/2011 | CN102250210A Human plasminogen Kringle 5 short peptide, its pharmaceutical composition, application and polynucleotide encoding the short peptide |
| 11/23/2011 | CN102250209A Novel HLA-A2 (Human Leukocyte Antigen-Alpha2) restrictive epitope polypeptide and application thereof |
| 11/23/2011 | CN102250208A New HLA-A2 restrictive epitope polypeptide and application thereof |
| 11/23/2011 | CN102250207A Novel human leukocyte antigen (HLA)-A2 limiting epitope polypeptide and use thereof |
| 11/23/2011 | CN102250206A New HLA-A2 restrictive epitope polypeptide and application thereof |
| 11/23/2011 | CN102250205A Preparation method of fatty acyl-RGD (Arg Gly Asp) induced docetaxel target liposome and antitumor activity thereof |
| 11/23/2011 | CN102250203A Beta-carboline aminoacid benzyl ester, preparation method and application thereof |
| 11/23/2011 | CN102250202A 1-paranitrophenyl-beta-carboline-3-formyl amine acid carbamates and synthesis method and use thereof |
| 11/23/2011 | CN102250190A Oleanolic saponin derivative, preparation method of salt thereof and application of derivative |
| 11/23/2011 | CN102250189A Glycyrrhetic acid derivative with 1, 12-diene-3-ketone skeleton, its preparation method and medicinal uses |
| 11/23/2011 | CN102250188A Ursolic acid series medicament with anti-inflammatory and anti-tumor activity and preparation thereof |
| 11/23/2011 | CN102250179A Stable protein kinase activator, and preparation method and purpose thereof |
| 11/23/2011 | CN102250176A Antitumor antibiotic ancomycin and its derivative |
| 11/23/2011 | CN102250150A Organic hydridized tetra-core platinum complex and preparation method thereof as well as application technology field of complex in antitumor medicament preparation |
| 11/23/2011 | CN102250149A Ionic iridium coordination compounds having weak coordinate bonds and preparation method and use thereof |
| 11/23/2011 | CN102250143A Imidazole benzamide compounds and application thereof in preparation of anti-malignant tumor medicaments |
| 11/23/2011 | CN102250138A Germatrane compound as well as preparation method and application thereof |
| 11/23/2011 | CN102250110A Magnesium cantharidate and preparation method thereof |
| 11/23/2011 | CN102250109A Phenol compounds as well as preparation method and application thereof |
| 11/23/2011 | CN102250106A Extraction method of sesquiterpene lactone compound from Chinese mugwort leaf and application thereof |
| 11/23/2011 | CN102250105A Camptothecin derivatives, synthesis method thereof and use thereof |